PortfoliosLab logoPortfoliosLab logo
ADM vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ADM vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Archer-Daniels-Midland Company (ADM) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ADM achieves a 41.55% return, which is significantly higher than NVO's -10.74% return. Over the past 10 years, ADM has outperformed NVO with an annualized return of 9.94%, while NVO has yielded a comparatively lower 7.56% annualized return.


ADM

1D
1.70%
1M
-2.56%
YTD
41.55%
6M
35.61%
1Y
66.67%
3Y*
6.06%
5Y*
6.96%
10Y*
9.94%

NVO

1D
-0.18%
1M
-6.80%
YTD
-10.74%
6M
-9.50%
1Y
-43.34%
3Y*
-15.59%
5Y*
2.92%
10Y*
7.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ADM vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ADM
Archer-Daniels-Midland Company
41.55%18.24%-27.52%-20.42%39.98%37.33%12.44%17.10%5.28%-9.48%
NVO
Novo Nordisk A/S
-10.74%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between ADM and NVO is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Apr 5, 1983

0.16

The correlation between ADM and NVO shifts across timeframes, from 0.05 (3 years) to 0.16 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ADM:

$38.84B

NVO:

$195.21B

EPS

ADM:

$2.23

NVO:

DKK 27.42

PE Ratio

ADM:

35.93

NVO:

10.34

PS Ratio

ADM:

0.48

NVO:

3.85

PB Ratio

ADM:

1.70

NVO:

6.21

Total Revenue (TTM)

ADM:

$80.61B

NVO:

DKK 327.80B

Gross Profit (TTM)

ADM:

$4.70B

NVO:

DKK 268.30B

EBITDA (TTM)

ADM:

$3.48B

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ADM vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADM
ADM Risk / Return Rank: 9292
Overall Rank
ADM Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
ADM Sortino Ratio Rank: 9292
Sortino Ratio Rank
ADM Omega Ratio Rank: 8989
Omega Ratio Rank
ADM Calmar Ratio Rank: 9393
Calmar Ratio Rank
ADM Martin Ratio Rank: 9393
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1212
Calmar Ratio Rank
NVO Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADM vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Archer-Daniels-Midland Company (ADM) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ADMNVODifference
Sharpe ratioReturn per unit of total volatility

+3.30

Sortino ratioReturn per unit of downside risk

+4.33

Omega ratioGain probability vs. loss probability

1.39

0.85

+0.54

Calmar ratioReturn relative to maximum drawdown

5.24

-0.80

+6.04

Martin ratioReturn relative to average drawdown

14.45

-1.18

+15.63

ADM vs. NVO - Sharpe Ratio Comparison

The current ADM Sharpe Ratio is 2.46, which is higher than the NVO Sharpe Ratio of -0.84. The chart below compares the historical Sharpe Ratios of ADM and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ADM vs. NVO - Drawdown Comparison

The maximum ADM drawdown since its inception was -68.01%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for ADM and NVO.


Loading charts...

Drawdown Indicators


ADMNVODifference

Max Drawdown

Largest peak-to-trough decline

-68.01%

-74.70%

+6.69%

Max Drawdown (1Y)

Largest decline over 1 year

-12.79%

-54.34%

+41.55%

Max Drawdown (3Y)

Largest decline over 3 years

-49.22%

-74.70%

+25.48%

Max Drawdown (5Y)

Largest decline over 5 years

-54.14%

-74.70%

+20.56%

Max Drawdown (10Y)

Largest decline over 10 years

-54.14%

-74.70%

+20.56%

Current Drawdown

Current decline from peak

-8.23%

-68.11%

+59.88%

Average Drawdown

Average peak-to-trough decline

-21.59%

-17.79%

-3.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.63%

37.62%

-32.99%

Volatility

ADM vs. NVO - Volatility Comparison

The current volatility for Archer-Daniels-Midland Company (ADM) is 7.74%, while Novo Nordisk A/S (NVO) has a volatility of 10.68%. This indicates that ADM experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ADMNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

7.74%

10.68%

-2.94%

Volatility (6M)

Calculated over the trailing 6-month period

19.56%

38.04%

-18.48%

Volatility (1Y)

Calculated over the trailing 1-year period

27.30%

51.88%

-24.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.26%

38.33%

-10.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.96%

32.56%

-5.60%

Dividends

ADM vs. NVO - Dividend Comparison

ADM's dividend yield for the trailing twelve months is around 2.57%, less than NVO's 4.11% yield.


PositionTTM20252024202320222021202020192018201720162015
ADM
Archer-Daniels-Midland Company
2.57%3.55%3.96%2.49%1.72%2.19%2.86%3.02%3.27%3.19%2.63%3.05%
NVO
Novo Nordisk A/S
4.11%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

ADM vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Archer-Daniels-Midland Company and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B40.00B60.00B80.00B100.00B20222023202420252026
20.49B
96.82B
(ADM) Total Revenue
(NVO) Total Revenue
Please note, different currencies. ADM values in USD, NVO values in DKK

ADM vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Archer-Daniels-Midland Company and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
6.0%
86.0%
Portfolio components
ADM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Archer-Daniels-Midland Company reported a gross profit of 1.22B and revenue of 20.49B. Therefore, the gross margin over that period was 6.0%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

ADM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Archer-Daniels-Midland Company reported an operating income of 408.00M and revenue of 20.49B, resulting in an operating margin of 2.0%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

ADM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Archer-Daniels-Midland Company reported a net income of 298.00M and revenue of 20.49B, resulting in a net margin of 1.5%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


ADM and NVO have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NVO has higher volatility (10.68%) compared to ADM (7.74%). In terms of maximum drawdown, ADM dropped -68.01% vs NVO's -74.70%.

ADM currently has the higher Sharpe Ratio (2.46 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ADM and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer